Next Article in Journal
Role of Specific Autoantibodies in Neurodegenerative Diseases: Pathogenic Antibodies or Promising Biomarkers for Diagnosis
Previous Article in Journal
Navigating the Challenges of Gluten Enteropathy and Infertility: The Role of Celiac-Related Antibodies and Dietary Changes
 
 
Article
Peer-Review Record

Neutralization of Different Variants of SARS-CoV-2 by a F(ab′)2 Preparation from Sera of Horses Immunized with the Viral Receptor Binding Domain

Antibodies 2023, 12(4), 80; https://doi.org/10.3390/antib12040080
by Mariajosé Rodriguez-Nuñez 1, Mariana del Valle Cepeda 2, Carlos Bello 2, Miguel Angel Lopez 2, Yoneira Sulbaran 1, Carmen Luisa Loureiro 1, Ferdinando Liprandi 3, Rossana Celeste Jaspe 1, Flor Helene Pujol 1,* and Héctor Rafael Rangel 1,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Antibodies 2023, 12(4), 80; https://doi.org/10.3390/antib12040080
Submission received: 2 September 2023 / Revised: 24 November 2023 / Accepted: 27 November 2023 / Published: 7 December 2023

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

This was a nicely presented paper. It would be of interest to include a little more context about equine immunoglobulin for passive immunotherapy.

I had several questions about Table 1. Concentration in mg/mL of what? F(ab')2 prep? Please explain 001 -- is this a pre-bleed? more details on 002 and 003 please ? Are these collected after different numbers of immunizations? timepoints?

Please make clear that the reduction in neutralization titer was in comparison to the ancestral strain titer.

I'm confused about the ELISA results included in the discussion. Is this your research? If so, please include in methods and results as well. 

 

there is a reference #34 that is not included in the ref list.

Comments on the Quality of English Language

The English could use some editing.  You can take out the word "ones" after the variant names. "titer" not "title" in your abstract. Take out "during immunization" and remove parentheses on line 52. Check ?, line 97. isolated= isolate line 127. I will leave the rest up to the editors of this journal!

Author Response

Reviewer 1

This was a nicely presented paper. It would be of interest to include a little more context about equine immunoglobulin for passive immunotherapy.

Thank you very much for your comment. More context about equine immunoglobulin for passive immunotherapy was included in the Introduction, lines 70-78 and 80-83.

 

I had several questions about Table 1.

We are sorry for the misleading information.

Concentration in mg/mL of what? F(ab')2 prep?

Yes. This information was included in Table 1.

Please explain 001 -- is this a pre-bleed?

more details on 002 and 003 please?

Are these collected after different numbers of immunizations? Time-points?

Preparation 001 is not a pre-bleed. The Table was corrected. More details were included in lines 99-101.

 

Please make clear that the reduction in neutralization titer was in comparison to the ancestral strain titer.

We apologize for the omission. This is now included in lines 23 (Abstract) and192-193.

 

I'm confused about the ELISA results included in the discussion. Is this your research? If so, please include in methods and results as well.

We apologize for the confusion. The ELISA results were from a previous study. This information was clarified in lines 217, 219 and 220.

 

 there is a reference #34 that is not included in the ref list.

We are sorry for the mistake in citing the references, which is now corrected. This reference is now reference 41.

 

Comments on the Quality of English Language

The English could use some editing.  You can take out the word "ones" after the variant names. "titer" not "title" in your abstract. Take out "during immunization" and remove parentheses on line 52. Check ?, line 97. isolated= isolate line 127. I will leave the rest up to the editors of this journal!

Thank you very much for your comments. We edited the manuscript accordingly and also checked the whole manuscript for English accuracy.

Reviewer 2 Report

Comments and Suggestions for Authors

This is very interesting. While it was expected that the changes in the virus would allow it to evade acquired immunity, it is very important that the data are actually presented.

 

I would have liked to see the results of more recent Omicron variants if possible, but I guess we should be thankful for the coverage up to BA.1.1, otherwise publication would have been delayed.

 

Author Response

Reviewer 2

This is very interesting. While it was expected that the changes in the virus would allow it to evade acquired immunity, it is very important that the data are actually presented.

Thank you very much for your comment.

 

I would have liked to see the results of more recent Omicron variants if possible, but I guess we should be thankful for the coverage up to BA.1.1, otherwise publication would have been delayed.

Thank you very much for your comment. Unfortunately, the BA.5 isolate was not available for this study.

Back to TopTop